Weiss Multi Strategy Advisers LLC Pulmonx Corp Transaction History

Weiss Multi Strategy Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$10.78 - $13.65 $853,032 - $1.08 Million	-79,131 Reduced 73.2%	28,977 $380,000
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $263,131 - $440,542	35,131 Added 48.14%	108,108 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $359,046 - $1.27 Million	72,977 New	72,977 $615,000
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $1.16 Million - $1.95 Million	-54,732 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $6,687 - $10,147	-225 Reduced 0.41%	54,732 $1.76 Million
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $36,627 - $45,280	1,018 Added 1.89%	54,957 $1.98 Million
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $21,813 - $27,840	580 Added 1.09%	53,939 $2.38 Million
Q1 2021 May 14, 2021	SELL	$44.0 - $67.54 $512,512 - $786,705	-11,648 Reduced 17.92%	53,359 $2.44 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $2.56 Million - $4.49 Million	65,007 New	65,007 $4.49 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.